✦ LIBER ✦

Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus

✍ Scribed by Joëlle A. Erkens; Ron M.C. Herings; Ronald P. Stolk; José A. Spoelstra; Diederick E. Grobbee; Hubert G.M. Leufkens

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Body mass index and cardiovascular risk

✍ Yafasov, K.M.; Ismailov, S.I.; Sirozhiddinova, N.Z.; Dubyanskaya, N.V.; Dubyansk 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Type 2 diabetes mellitus in adolescence:

✍ Kenneth Lee Jones; Asheesh Kumar Dewan 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 451 KB

Asymmetric dimethylarginine as a risk fa

✍ Ippei Kanazawa; Shozo Yano; Yoshitomo Notsu; Toru Yamaguchi; Toru Nabika; Toshit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Effect of metformin treatment on multipl

✍ Fahim Abbasi; James W Chu; Tracey McLaughlin; Cindy Lamendola; Elizabeth T Leary 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

T04-P-001 Cardiovascular risk factors in

✍ Aasvee, K.E.; Kmvinen, E.; Roovere, T.; Tupits, H.; Hedman, A.; Jauhiainen, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Insulin treatment improves microalbuminu

✍ Dr T. Lindström; A. G. Olsson; H. Von Schenck; L. Wallentin; H. J. Arnqvist 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB